NEXI

Q: What is the price of NexImmune (NEXI) today?

The current price of NexImmune (NEXI) is $ 0.000100, representing a 0% gain over the past year. The stock began the year trading around $ 0.000100 and is currently priced at $ 0.000100. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does NexImmune (NEXI) pay dividends?

NexImmune (NEXI) did not pay dividends over the past year.

Q: Is NexImmune (NEXI) a good investment?

NexImmune (NEXI) is currently trading at $ 0.000100 with a P/E ratio of 0.00%. This represents a -2% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

NexImmune Inc.

Price

$ 0.000100

return (12m)

0.00%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

NEXI price

NEXI

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment NEXI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-50.00%

3 months

0.00%

1 year

0.00%

2 years

-100.00%

5 years

-100.00%

10 years

0.00%

Fundamentals NEXI

review the fundamentals of NexImmune shares

P/E

0.00

Sector: -3.90 Industry: -3.90

0.84

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-16.65%

Sector: - Industry: -

Fundamentals NEXI

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.84	7.39	33.81%	2.14%	$ 585.48 B	28.46%
PFE	20.72	1.73	8.35%	6.07%	$ 161.03 B	12.42%
ABBV	87.32	0.00	0.00%	3.18%	$ 369.02 B	6.91%
NVO	10.48	5.40	51.50%	4.56%	$ 164.23 B	33.05%
MRK	16.43	0.00	0.00%	2.71%	$ 300.00 B	28.08%
AZN	30.87	6.48	20.99%	1.57%	$ 315.61 B	17.41%
GILD	20.39	7.67	37.62%	2.28%	$ 173.52 B	28.90%
BMY	17.20	-3.56	-20.72%	4.18%	$ 121.35 B	14.64%
ZTS	19.33	15.51	80.25%	1.72%	$ 51.66 B	28.23%
REGN	17.42	2.51	14.41%	0.47%	$ 78.47 B	31.41%
HALO	24.01	155.91	649.21%	0.00%	$ 7.61 B	22.69%
AMGN	24.32	21.66	89.06%	2.78%	$ 187.54 B	20.98%
MCK	24.84	-1,089.08	-4,383.84%	0.36%	$ 107.82 B	1.09%
VRTX	28.19	5.97	21.18%	0.00%	$ 111.43 B	32.94%
CAH	30.39	-18.71	-61.56%	0.95%	$ 50.52 B	0.68%
HRMY	9.96	1.82	18.24%	0.00%	$ 1.58 B	18.27%
ADMA	14.89	4.58	30.78%	0.00%	$ 2.19 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

NEXI Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT NexImmune

NexImmune Inc.

Average Investor10 user rating

4.0 (0 people)

United States

15 years

Founded: 2011

2021

Time since IPO - 5 years

44

Employees

NexImmune Inc. (United States) is listed on the Nasdaq and has a market capitalization of $100.00 , with shareholders equity totaling $920.00 Thousand.

The company employs approximately 44 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, NexImmune Inc. reported $- in revenue, generating net income of $-20.62 Millions.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NEXI.

Market cap

$ 100.00

Net worth

$ 920.00 Thousand

$ 920,000.00

Assets

$ 5.86 Millions

$ 5,860,000.00

Total Shares Outstanding

1.00 Million

1,000,000

Average Daily Trading Volume

$ 54.54

Sector

Health Care

Industry

Biotechnology

NEXI

NEXI revenue and profits

Financial Results NEXI

DRAG THE FRAME TO SEE MORE DATA

NEXI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 876.58 27,66% (12M)

P/E

24.84

0.36%

ROE

-4,383.84%

P/BV

-1,089.08

CAH - Cardinal Health

$ 216.80 66,99% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.71

JNJ - Johnson & Johnson

$ 243.50 64,95% (12M)

P/E

21.84

2.14%

ROE

33.81%

P/BV

7.39

PFE - Pfizer

$ 27.41 34,18% (12M)

P/E

20.72

6.07%

ROE

8.35%

P/BV

1.73

ABBV - AbbVie

$ 212.90 26,65% (12M)

P/E

87.32

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 122.97 60,95% (12M)

P/E

16.43

2.71%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 206.17 54,28% (12M)

P/E

30.87

1.57%

ROE

20.99%

P/BV

6.48

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 876.58 27,66% (12 M)

P/L

24.84

0.36%

ROE

-4,383.84%

P/VP

-1,089.08

CAH - Cardinal Health

$ 216.80 66,99% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.71

JNJ - Johnson & Johnson

$ 243.50 64,95% (12 M)

P/L

21.84

2.14%

ROE

33.81%

P/VP

7.39

PFE - Pfizer

$ 27.41 34,18% (12 M)

P/L

20.72

6.07%

ROE

8.35%

P/VP

1.73

ABBV - AbbVie

$ 212.90 26,65% (12 M)

P/L

87.32

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 122.97 60,95% (12 M)

P/L

16.43

2.71%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 206.17 54,28% (12 M)

P/L

30.87

1.57%

ROE

20.99%

P/VP

6.48

Frequently Asked Questions

What is the price of NexImmune (NEXI) today?

The current price of NexImmune (NEXI) is $ 0.000100, representing a 0% gain over the past year. The stock began the year trading around $ 0.000100 and is currently priced at $ 0.000100. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does NexImmune (NEXI) pay dividends?

NexImmune (NEXI) did not pay dividends over the past year.

Is NexImmune (NEXI) a good investment?

NexImmune (NEXI) is currently trading at $ 0.000100 with a P/E ratio of 0.00%. This represents a -2% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy NexImmune (NEXI) stock?

You can buy NexImmune (NEXI) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol NEXI and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of NexImmune (NEXI) yield today?

Over the past month, NexImmune (NEXI) has returned -50.00% — 0.00% over the past year, and -100.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of NexImmune (NEXI) today at the current price of $ 0.000100 your total investment would be $ 0.01.

Based on historical performance, the investment would have grown to approximately:

$ 0.01 after 1 year
$ 0.00 after 5 years
$ 0.01 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NEXI

NexImmune Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NEXI

review the fundamentals of NexImmune shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT NexImmune

NexImmune Inc.

United States

15 years

2021

44

PROFIT X PRICE NEXI

Financial Results NEXI

NEXI cash flow

Asset, Revenue and Profit Growth - NEXI

NEXI balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions